Cargando…
Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy
The absence of tumor antigens leads to a low response rate, which represents a major challenge in immune checkpoint blockade (ICB) therapy. Pyroptosis, which releases tumor antigens and damage‐associated molecular patterns (DAMPs) that induce antitumor immunity and boost ICB efficiency, potentially...
Autores principales: | Xiao, Yao, Zhang, Tian, Ma, Xianbin, Yang, Qi‐Chao, Yang, Lei‐Lei, Yang, Shao‐Chen, Liang, Mengyun, Xu, Zhigang, Sun, Zhi‐Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693073/ https://www.ncbi.nlm.nih.gov/pubmed/34705343 http://dx.doi.org/10.1002/advs.202101840 |
Ejemplares similares
-
Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity
por: Yang, Qichao, et al.
Publicado: (2022) -
Stepwise Size Shrinkage Cascade‐Activated Supramolecular Prodrug Boosts Antitumor Immunity by Eliciting Pyroptosis
por: Liang, Meng‐Yun, et al.
Publicado: (2022) -
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
por: Ma, Xianbin, et al.
Publicado: (2022) -
Sonodynamic-immunomodulatory nanostimulators activate pyroptosis and remodel tumor microenvironment for enhanced tumor immunotherapy
por: Chen, Zhuang, et al.
Publicado: (2023) -
Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer
por: Wang, Meng, et al.
Publicado: (2022)